Nate's Weekly Stock Picks are Here: It's Monday Morning and our Lead Technical Tactician Nate Bear is giving you his weekly stocks to watch. This week he's looking at another play in the artificial intelligence sector. Click the image below to see the chart. Last week Nate hit a big winner, closing a 255% gain on Carvana (CVNA) in 2 trading days. Click here to learn more about Nate's mission to turn $37,000 into $1 million. Good morning Wake-up Watchlisters! While you're sipping coffee you'll see stock futures were little changed on Monday while oil declined over 2%. Traders will be focusing on key data releases this week, including the May inflation reading on Tuesday and a new Fed decision on Wednesday. To see how we're playing the data, we invite you to join us in The War Room. Bryan and Karim have been on fire. Last month, They made 35 trades and 32 of them were winners for a 92% win rate. They also netted several triple baggers, including two 200%+ overnight gains on URBN and AAP. Click here to unlock The War Room and start making overnight trades in realtime. Here's a look at the top-moving stocks this morning. Chinook Therapeutics (Nasdaq: KDNY) Chinook Therapeutics is up 65.90% premarket after agreeing to be acquired by Novartis for $40 per share in cash. Under the agreement, Novartis will acquire Chinook for $3.2 billion, offering $40 per share in cash. This represents a significant premium of 83 percent to Chinook's 60-day volume-weighted average stock price and 67 percent to its closing price on June 9, 2023. In addition to the cash payment, Chinook shareholders will receive contingent value rights (CVRs) that could provide an additional $4 per share upon the accomplishment of specific regulatory milestones related to Chinook's primary product candidate, atrasentan. The total consideration, including the CVRs, could amount to approximately $3.5 billion. |
No comments:
Post a Comment